Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut — Plainville, Connecticut

Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut is a clinical research site located in Plainville, Connecticut, United States 06062.

Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.

Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: Advanced Solid Tumors, Small Cell Lung Cancer (SCLC), Relapsed or Refractory Multiple Myeloma.

Sponsors: Astellas Pharma Global Development, Inc., Amgen, Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Plainville

Browse all research sites in Connecticut · View every site in Plainville

• Cancer Center Of Central Connecticut
• Central Connecticut Endoscopy Center
• Pharmacosmos Investigational Site
• Wheeler Community Healthcare
• Wheeler Clinic
• Local Institution - 0007
• Local Institution - 0044
• 1199.52.0101 Boehringer Ingelheim Investigational Site
• MorphoSys Research Site
• Hartford HealthCare Cancer Institute - Manchester
• Research Site

Sponsor Feasibility Report

Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut?

Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut conducted?

Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut has 6 clinical trials on record, with 2 currently active. Their work covers Advanced Solid Tumors, Small Cell Lung Cancer (SCLC), Relapsed or Refractory Multiple Myeloma.

Is Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut accredited by Crixeo Clinical Trials?

Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.